Global Interventional Oncology Devices Market: Focus on Devices/Therapies Cancer Types, Regional Analysis, Data – Analysis and Forecast, 2019-2025
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Key Questions Answered in this Report:
Interventional Oncology Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 9.0% during the forecast period 2019-2025. The interventional oncology devices market generated $2.20 billion revenue in 2018, in terms of value.
The interventional oncology devices growth has been primarily attributed to the major drivers in this market such as increasing prevalence and growing incidence of cancer, favourable reimbursement scenario for interventional oncology treatment in developed countries, high preference for minimally invasive surgical procedures, availability of private and government funding, and others. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product launches, and increasing merger and acquisitions among the industry players. However, there are significant challenges which are restraining the market growth. These challenges include increasing financial burden on industry players with high number of product recalls and lack of clinical evidences for localized region treatment.
Expert Quote
'The addition of the BTG Interventional Medicine portfolio reinforces our category leadership strategy and enables us to offer best-in-class technologies, unparalleled clinical evidence and a strengthened commercial infrastructure to support physicians treating some of the most challenging diseases impacting patient health around the world,'
Scope of the Market Intelligence on Interventional Oncology Devices Market
The interventional oncology devices market research provides a holistic view of global market in terms of various factors influencing it, including regulatory reforms, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products used in interventional oncology procedures. In addition, the study also includes exhaustive information on impact of interventional oncology devices on various cancer types, perception on the new product launches, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segments, and company, as well as other vital information with respect to global interventional oncology devices market.
Market Segmentation
The interventional oncology devices market segmentation (based on product) is further segmented into embolization devices (transcatheter arterial radioembolization, transcatheter arterial chemoembolization, transcatheter arterial embolization), ablation devices (radiofrequency ablation, microwave ablation, and cryoablation), supporting devices, and next-gen devices.
The interventional oncology devices market segmentation (based on cancer type) is further segmented into liver, lung, kidney, prostate, and other cancer types.
Key Companies in the Global Interventional Oncology Devices Market
The key manufacturers who have been contributing significantly to the interventional oncology devices market include AngioDynamics Inc., BD, BTG PLC, Boston Scientific Corporation, HealthTronics Inc., Medtronic PLC, Merit Medical Systems Inc., Sirtex Medical Ltd., and Terumo Corporation, among others.
Key Questions Answered in this Report:
- What are the key features of interventional oncology devices which makes them a better choice for the treatment of cancer?
- What is the industry structure of the interventional oncology devices market?
- How did the interventional oncology devices market evolve and what is its scope in the future?
- What are the key development strategies which are implemented by the key players to maintain and capture market share?
- What are the major market drivers, challenges, and opportunities in the global interventional oncology devices market?
- What are the current leading companies dominating the global interventional oncology devices market?
- What are the regulations pertaining to the global interventional oncology devices market? What are the initiatives implemented by different government bodies to reduce the incidence of cancer?
- What was the market value of the leading segments and sub-segments of the global interventional oncology devices market?
- How is each segment of the global interventional oncology devices market expected to grow during the forecast period and what is the revenue expected to be generated by each of the segments by the end of 2025?
- Which region carries the potential for the significant expansion of key companies for interventional oncology devices market?
Interventional Oncology Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 9.0% during the forecast period 2019-2025. The interventional oncology devices market generated $2.20 billion revenue in 2018, in terms of value.
The interventional oncology devices growth has been primarily attributed to the major drivers in this market such as increasing prevalence and growing incidence of cancer, favourable reimbursement scenario for interventional oncology treatment in developed countries, high preference for minimally invasive surgical procedures, availability of private and government funding, and others. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product launches, and increasing merger and acquisitions among the industry players. However, there are significant challenges which are restraining the market growth. These challenges include increasing financial burden on industry players with high number of product recalls and lack of clinical evidences for localized region treatment.
Expert Quote
'The addition of the BTG Interventional Medicine portfolio reinforces our category leadership strategy and enables us to offer best-in-class technologies, unparalleled clinical evidence and a strengthened commercial infrastructure to support physicians treating some of the most challenging diseases impacting patient health around the world,'
Scope of the Market Intelligence on Interventional Oncology Devices Market
The interventional oncology devices market research provides a holistic view of global market in terms of various factors influencing it, including regulatory reforms, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products used in interventional oncology procedures. In addition, the study also includes exhaustive information on impact of interventional oncology devices on various cancer types, perception on the new product launches, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segments, and company, as well as other vital information with respect to global interventional oncology devices market.
Market Segmentation
The interventional oncology devices market segmentation (based on product) is further segmented into embolization devices (transcatheter arterial radioembolization, transcatheter arterial chemoembolization, transcatheter arterial embolization), ablation devices (radiofrequency ablation, microwave ablation, and cryoablation), supporting devices, and next-gen devices.
The interventional oncology devices market segmentation (based on cancer type) is further segmented into liver, lung, kidney, prostate, and other cancer types.
Key Companies in the Global Interventional Oncology Devices Market
The key manufacturers who have been contributing significantly to the interventional oncology devices market include AngioDynamics Inc., BD, BTG PLC, Boston Scientific Corporation, HealthTronics Inc., Medtronic PLC, Merit Medical Systems Inc., Sirtex Medical Ltd., and Terumo Corporation, among others.
EXECUTIVE SUMMARY
1 PRODUCT DEFINITION
1.1 Embolization devices
1.2 Ablation devices
1.3 Supporting devices
1.4 Next Gen devices
2 SCOPE OF THE REPORT
3 RESEARCH METHODOLOGY
3.1 Research Methodology
4 INDUSTRY ANALYSIS
4.1 Regulatory Framework
4.2 Patent Analysis
5 COMPETITIVE LANDSCAPE
5.1 Key Strategies and Developments
5.1.1 Product Launches
5.1.2 Collaborations, Joint Ventures, and Partnerships
5.1.3 Mergers and Acquisitions
5.1.4 Awards, Recognitions, and Funding
5.1.5 Business Expansion
5.2 Vendor Market Share Analysis (2018)
6 MARKET DYNAMICS
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.3.1 High Prevalence and Growing Incidences of Cancer
6.3.2 Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Countries
6.3.3 High preference for Minimally Invasive Surgical Procedures
6.3.4 Expanding Role of Interventional Oncology in the Treatment of Cancer
6.3.5 Availability of Private and Government Funding and Grants for Research in the Field of Interventional Oncology
6.3.6 Rising Awareness among People for the Treatment of Cancer
6.3.7 Increase in Disposable Income
6.4 Market Challenges
6.4.1 Financial Burden of Product Recalls
6.4.2 Lack of Clinical Evidences for Locoregional Treatments
6.5 Market Opportunities
6.5.1 High Growth Opportunity in the Emerging Economies
6.6 Market Restraints
6.6.1 Dearth of Trained Interventional Oncologists
7 GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET (BY CANCER TYPE)
7.1 Overview
7.2 Liver Cancer
7.3 Lung Cancer
7.4 Kidney Cancer
7.5 Prostate Cancer
7.6 Other Cancers
8 GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET (BY PRODUCT TYPE)
8.1 Overview
8.2 Ablation Devices
8.2.1 Radiofrequency Ablation (RFA)
8.2.2 Microwave Ablation
8.2.3 Cryoablation
8.3 Embolization Devices
8.3.1 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
8.3.2 Transcatheter Arterial Chemoembolization
8.3.3 Transcatheter Arterial Embolization/Bland Embolization
8.4 Supporting Devices
8.4.1 Catheters
8.4.2 Guidewires
8.5 Next Generation Devices
8.5.1 Irreversible Electroporation Ablation
8.5.2 Percutaneous Ethanol Ablation
8.5.3 High Intensity Focused Ultrasound
8.5.4 Laser Ablation
8.5.5 Photothermal Ablation
8.5.6 Theranostics
9 GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET (BY REGION)
9.1 Global Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest-of-Asia-Pacific
9.5 Rest-of-the-World
9.5.1 Latin America
9.5.2 Middle East and Africa
10 COMPANY PROFILES
10.1 Overview
10.2 AngioDynamics, Inc.
10.2.1 Company Overview
10.2.2 Role of AngioDynamics, Inc. in the Global Interventional Oncology Devices Market
10.2.3 Key Developments
10.2.4 Financials
10.2.5 SWOT Analysis
10.3 BD
10.3.1 Company Overview
10.3.2 Role of BD in the Global Advanced Interventional Oncology Devices Market
10.3.3 Financials
10.3.4 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Role of Boston Scientific Corporation in the Global Interventional Oncology Devices Market
10.4.3 Key Development
10.4.4 Financials
10.4.5 SWOT Analysis
10.5 BTG Plc
10.5.1 Company Overview
10.5.2 Role of BTG Plc in the Global Interventional Oncology Devices Market
10.5.3 Key Development
10.5.4 Financials
10.5.5 SWOT Analysis
10.6 Eckert & Ziegler BEBIG
10.6.1 Company Overview
10.6.2 Role of Eckert & Ziegler BEBIG AG in the Global Advanced Interventional Oncology Devices Market
10.6.3 Financials
10.6.4 SWOT Analysis
10.7 HealthTronics, Inc.
10.7.1 Company Overview
10.7.2 Role of HealthTronics, Inc. in the Global Interventional Oncology Devices Market
10.7.3 SWOT Analysis
10.8 IceCure Medical
10.8.1 Company Overview
10.8.2 Role of IceCure Medical in the Global Interventional Oncology Devices Market
10.8.3 Key Development
10.8.4 SWOT Analysis
10.9 Medtronic PLC
10.9.1 Overview
10.9.2 Role of Medtronic PLC in the Global Interventional Oncology Devices Market
10.9.3 Key Development
10.9.4 Financials
10.9.5 SWOT Analysis
10.10 Medwaves, Inc.
10.10.1 Company Overview
10.10.2 Role of MedWaves, Inc. in the Global Interventional Oncology Devices Market
10.10.3 SWOT Analysis
10.11 Merit Medical Systems, Inc.
10.11.1 Company Overview
10.11.2 Role of Merit Medical Systems, Inc. in the Global Interventional Oncology Devices Market
10.11.3 Financials
10.11.4 SWOT Analysis
10.12 Sanarus Technologies, Inc.
10.12.1 Company Overview
10.12.2 Role of Sanarus Technologies, Inc. in the Global Interventional Oncology Devices Market
10.12.3 Key Developement
10.12.4 SWOT Analysis
10.13 Sirtex Medical Ltd. (China Grand Pharmaceutical and Healthcare Holdings Limited; CDH Genetech, Ltd.)
10.13.1 Company Overview
10.13.2 Role of Sirtex Medical Ltd. in the Global Advanced Interventional Oncology Devices Market
10.13.3 Financials
10.13.4 SWOT Analysis
10.14 Sonacare Medical
10.14.1 Company Overview
10.14.2 Role of Sonacare Medical in the Global Interventional Oncology Devices Market
10.14.3 Key Developement
10.14.4 SWOT Analysis
10.15 Terumo Corporation
10.15.1 Company Overview
10.15.2 Role of Terumo Corporation in the Global Interventional Oncology Devices Market
10.15.3 Financials
10.15.4 SWOT Analysis
10.16 Trod Medical
10.16.1 Company Overview
10.16.2 Role of Trod Medical in the Global Interventional Oncology Devices Market
10.16.3 SWOT Analysis
1 PRODUCT DEFINITION
1.1 Embolization devices
1.2 Ablation devices
1.3 Supporting devices
1.4 Next Gen devices
2 SCOPE OF THE REPORT
3 RESEARCH METHODOLOGY
3.1 Research Methodology
4 INDUSTRY ANALYSIS
4.1 Regulatory Framework
4.2 Patent Analysis
5 COMPETITIVE LANDSCAPE
5.1 Key Strategies and Developments
5.1.1 Product Launches
5.1.2 Collaborations, Joint Ventures, and Partnerships
5.1.3 Mergers and Acquisitions
5.1.4 Awards, Recognitions, and Funding
5.1.5 Business Expansion
5.2 Vendor Market Share Analysis (2018)
6 MARKET DYNAMICS
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.3.1 High Prevalence and Growing Incidences of Cancer
6.3.2 Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Countries
6.3.3 High preference for Minimally Invasive Surgical Procedures
6.3.4 Expanding Role of Interventional Oncology in the Treatment of Cancer
6.3.5 Availability of Private and Government Funding and Grants for Research in the Field of Interventional Oncology
6.3.6 Rising Awareness among People for the Treatment of Cancer
6.3.7 Increase in Disposable Income
6.4 Market Challenges
6.4.1 Financial Burden of Product Recalls
6.4.2 Lack of Clinical Evidences for Locoregional Treatments
6.5 Market Opportunities
6.5.1 High Growth Opportunity in the Emerging Economies
6.6 Market Restraints
6.6.1 Dearth of Trained Interventional Oncologists
7 GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET (BY CANCER TYPE)
7.1 Overview
7.2 Liver Cancer
7.3 Lung Cancer
7.4 Kidney Cancer
7.5 Prostate Cancer
7.6 Other Cancers
8 GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET (BY PRODUCT TYPE)
8.1 Overview
8.2 Ablation Devices
8.2.1 Radiofrequency Ablation (RFA)
8.2.2 Microwave Ablation
8.2.3 Cryoablation
8.3 Embolization Devices
8.3.1 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
8.3.2 Transcatheter Arterial Chemoembolization
8.3.3 Transcatheter Arterial Embolization/Bland Embolization
8.4 Supporting Devices
8.4.1 Catheters
8.4.2 Guidewires
8.5 Next Generation Devices
8.5.1 Irreversible Electroporation Ablation
8.5.2 Percutaneous Ethanol Ablation
8.5.3 High Intensity Focused Ultrasound
8.5.4 Laser Ablation
8.5.5 Photothermal Ablation
8.5.6 Theranostics
9 GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET (BY REGION)
9.1 Global Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest-of-Asia-Pacific
9.5 Rest-of-the-World
9.5.1 Latin America
9.5.2 Middle East and Africa
10 COMPANY PROFILES
10.1 Overview
10.2 AngioDynamics, Inc.
10.2.1 Company Overview
10.2.2 Role of AngioDynamics, Inc. in the Global Interventional Oncology Devices Market
10.2.3 Key Developments
10.2.4 Financials
10.2.5 SWOT Analysis
10.3 BD
10.3.1 Company Overview
10.3.2 Role of BD in the Global Advanced Interventional Oncology Devices Market
10.3.3 Financials
10.3.4 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Role of Boston Scientific Corporation in the Global Interventional Oncology Devices Market
10.4.3 Key Development
10.4.4 Financials
10.4.5 SWOT Analysis
10.5 BTG Plc
10.5.1 Company Overview
10.5.2 Role of BTG Plc in the Global Interventional Oncology Devices Market
10.5.3 Key Development
10.5.4 Financials
10.5.5 SWOT Analysis
10.6 Eckert & Ziegler BEBIG
10.6.1 Company Overview
10.6.2 Role of Eckert & Ziegler BEBIG AG in the Global Advanced Interventional Oncology Devices Market
10.6.3 Financials
10.6.4 SWOT Analysis
10.7 HealthTronics, Inc.
10.7.1 Company Overview
10.7.2 Role of HealthTronics, Inc. in the Global Interventional Oncology Devices Market
10.7.3 SWOT Analysis
10.8 IceCure Medical
10.8.1 Company Overview
10.8.2 Role of IceCure Medical in the Global Interventional Oncology Devices Market
10.8.3 Key Development
10.8.4 SWOT Analysis
10.9 Medtronic PLC
10.9.1 Overview
10.9.2 Role of Medtronic PLC in the Global Interventional Oncology Devices Market
10.9.3 Key Development
10.9.4 Financials
10.9.5 SWOT Analysis
10.10 Medwaves, Inc.
10.10.1 Company Overview
10.10.2 Role of MedWaves, Inc. in the Global Interventional Oncology Devices Market
10.10.3 SWOT Analysis
10.11 Merit Medical Systems, Inc.
10.11.1 Company Overview
10.11.2 Role of Merit Medical Systems, Inc. in the Global Interventional Oncology Devices Market
10.11.3 Financials
10.11.4 SWOT Analysis
10.12 Sanarus Technologies, Inc.
10.12.1 Company Overview
10.12.2 Role of Sanarus Technologies, Inc. in the Global Interventional Oncology Devices Market
10.12.3 Key Developement
10.12.4 SWOT Analysis
10.13 Sirtex Medical Ltd. (China Grand Pharmaceutical and Healthcare Holdings Limited; CDH Genetech, Ltd.)
10.13.1 Company Overview
10.13.2 Role of Sirtex Medical Ltd. in the Global Advanced Interventional Oncology Devices Market
10.13.3 Financials
10.13.4 SWOT Analysis
10.14 Sonacare Medical
10.14.1 Company Overview
10.14.2 Role of Sonacare Medical in the Global Interventional Oncology Devices Market
10.14.3 Key Developement
10.14.4 SWOT Analysis
10.15 Terumo Corporation
10.15.1 Company Overview
10.15.2 Role of Terumo Corporation in the Global Interventional Oncology Devices Market
10.15.3 Financials
10.15.4 SWOT Analysis
10.16 Trod Medical
10.16.1 Company Overview
10.16.2 Role of Trod Medical in the Global Interventional Oncology Devices Market
10.16.3 SWOT Analysis
LIST OF TABLES
Table 4.1: Regulatory Bodies Related to Interventional Oncology Devices (by Country)
Table 6.1: Impact Analysis of Market Drivers
Table 6.2: Impact Analysis of Market Challenges
Table 6.3: Global Age Standardized Cancer Rates (Per 100,000 People) by Country, 2018
Table 6.4: Reimbursement Scenario for Hepatic Embolization in U.S., 2018
Table 6.5: Reimbursement Scenario for Renal Embolization in U.S., 2018
Table 9.1: Canadian Cancer Statistics 2019 Snapshot of Incidence, Mortality and Survival Estimates (by Cancer Type)
Table 4.1: Regulatory Bodies Related to Interventional Oncology Devices (by Country)
Table 6.1: Impact Analysis of Market Drivers
Table 6.2: Impact Analysis of Market Challenges
Table 6.3: Global Age Standardized Cancer Rates (Per 100,000 People) by Country, 2018
Table 6.4: Reimbursement Scenario for Hepatic Embolization in U.S., 2018
Table 6.5: Reimbursement Scenario for Renal Embolization in U.S., 2018
Table 9.1: Canadian Cancer Statistics 2019 Snapshot of Incidence, Mortality and Survival Estimates (by Cancer Type)
LIST OF FIGURES
Figure 1: Global Interventional Oncology Devices Market: Market Segmentation
Figure 2: Market Statistics
Figure 3: Global Interventional Oncology Devices Market, 2018-2025
Figure 4: Market Drivers and Market Restraints
Figure 5: Financial Burden of Cancer (2015)
Figure 6: Share of Prevalence of Cancer in Global Population
Figure 7: Number of People with Cancer (by Age) in Global Population
Figure 8: Growth Share Matrix of Interventional Oncology Devices Market, by Products, 2019-2025
Figure 9: Global Interventional Oncology Devices Market, by Cancer Type, 2018 and 2025
Figure 10: Global Interventional Oncology Devices Market, by Geography, 2018 and 2025
Figure 11: Competitive Scenario
Figure 2.1: Global Interventional Oncology Devices Market: Market Segmentation
Figure 3.1: Interventional oncology devices Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.6: Assumptions and Limitations
Figure 3.7: Factors Considered for Data Prediction and Modeling
Figure 4.1: Share of Patents (by Ownership), 2015-2018
Figure 5.1: Competitive Landscape, January 2015-February 2019
Figure 5.2: Share of Key Developments and Strategies, January 2015-February 2019
Figure 5.3: Product Launches (by Company), January 2015-February 2019
Figure 5.4: Collaborations, Joint Ventures, and Partnerships Share (by Company), January 2015-February 2019
Figure 5.5: Mergers and Acquisitions Share (by Company), January 2015- February 2019
Figure 5.6: Awards and Recognition (by Company), January 2015-February 2019
Figure 5.7: Business Expansion and Others Share (by Company), January 2015- February 2019
Figure 5.8: Market Share Analysis (by Company), for Global Interventional Oncology Devices Market, 2018
Figure 6.1: Market Dynamics
Figure 6.2: Trend of Robotic Surgery, Laparoscopic Surgery and Open Surgery, as a % of Select Surgeries, 2006 to 2015, U.K.
Figure 6.3: Household Disposable Income, US$/Capita
Figure 7.1: Segmentation of Interventional Oncology Devices Market (by Cancer Type)
Figure 7.2: Global Interventional Oncology Devices Market (by Cancer type), 2018 and 2025
Figure 7.3: Global Interventional Oncology Devices Market (Liver Cancer), 2018-2025
Figure 7.4: Global Interventional Oncology Devices Market (Lung Cancer), 2018-2025
Figure 7.5: Global Interventional Oncology Devices Market (Kidney Cancer), 2018-2025
Figure 7.6: Global Interventional Oncology Devices Market (Prostate Cancer), 2018-2025
Figure 7.7: Global Interventional Oncology Devices Market (by Other Cancers), 2018-2025
Figure 8.1: Segmentation of Interventional Oncology Devices Market (by Product type)
Figure 8.2: Global Interventional Oncology Devices Market (by Product type), 2018 and 2025
Figure 8.3: Global Interventional Oncology Devices Market (Ablation Devices), 2018-2025
Figure 8.4: Ablation is mainly divided into 3 types:
Figure 8.5. : Global Interventional Oncology Devices Market (Radiofrequency ablation devices), 2018-2025
Figure 8.6: Global Interventional Oncology Devices Market (Microwave Ablation Devices), 2018-2025
Figure 8.7: Global Interventional Oncology Devices Market (by Cryoablation Ablation Devices), 2018-2025
Figure 8.8: Global Interventional Oncology Devices Market (Embolization Devices), 2018-2025
Figure 8.9: Embolization is mainly divided into three types:
Figure 8.10: Global Interventional Oncology Devices Market (Transcatheter Arterial Radioembolization Devices), 2018-2025
Figure 8.11: Global Interventional Oncology Devices Market (Transcatheter arterial chemoembolization Devices), 2018-2025
Figure 8.12: Global Interventional Oncology Devices Market (Transcatheter arterial embolization devices), 2018-2025
Figure 8.13: Global Interventional Oncology Devices Market (Supporting Devices), 2018-2025
Figure 8.14: Global Interventional Oncology Devices Market (Next Generation Devices), 2018-2025
Figure 9.1: Global Interventional Oncology Devices Market (by Region), 2018 and 2025
Figure 9.2: North America: Interventional Oncology Devices Market, 2018-2025
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America: Interventional Oncology Devices Market (by Country), 2018 and 2025
Figure 9.5: U.S.: Interventional Oncology Devices Market, 2018-2025
Figure 9.6: Canada: Interventional Oncology Devices Market, 2018-2025
Figure 9.7: Europe: Interventional Oncology Devices Market, 2018-2025
Figure 9.8: Europe: Market Dynamics
Figure 9.9: Europe: Interventional Oncology Devices Market (by Country), 2018 and 2024
Figure 9.10: Germany: Interventional Oncology Devices Market, 2018-2025
Figure 9.11: France: Interventional oncology Devices Market, 2018-2025
Figure 9.12: U.K.: Interventional Oncology Devices Market, 2018-2025
Figure 9.13: Italy: Interventional Oncology Devices Market, 2018-2025
Figure 9.14: Rest-of-Europe: Interventional Oncology Devices Market, 2018-2025
Figure 9.15: Asia-Pacific: Interventional Oncology Devices Market, 2018-2025
Figure 9.16: Asia-Pacific: Market Dynamics
Figure 9.17: Asia-Pacific: Interventional Oncology Devices Market (by Country), 2018 and 2024
Figure 9.18: China: Interventional Oncology Devices Market, 2018-2025
Figure 9.19: Japan: Interventional Oncology Devices Market, 2018-2025
Figure 9.20: India: Interventional Oncology Devices Market, 2018-2025
Figure 9.21: Australia: Interventional Oncology Devices Market, 2018-2025
Figure 9.22: Rest-of-Asia-Pacific: Interventional Oncology Devices Market, 2018-2025
Figure 9.23: Rest-of-the-World: Interventional Oncology Devices Market, 2018-2025
Figure 9.24: Latin America: Interventional Oncology Devices Market, 2018-2025
Figure 9.25: Middle East and Africa: Interventional Oncology Devices Market, 2018-2025
Figure 10.1: Number of Companies Profiled: Global Interventional Oncology Devices Market, 2018
Figure 10.2: AngioDynamics, Inc.: Product Portfolio
Figure 10.3: AngioDynamics, Inc., Overall Financials, 2016-2018
Figure 10.4: AngioDynamics Inc., Total Sales Revenue (by Segment), 2016-2018
Figure 10.5: AngioDynamics, Inc. (by Region), 2016-2018
Figure 10.6: AngioDynamics Inc., R&D Expenditure, 2016-2018
Figure 10.7: AngioDynamics, Inc.: SWOT Analysis
Figure 10.8: BD: Product Portfolio
Figure 10.9: BD, Overall Financials, 2016-2018
Figure 10.10: BD, Total Sales Revenue (by Segment), 2016-2018
Figure 10.11: BD (by Region), 2016-2018
Figure 10.12: BD, Total Sales Revenue, 2016-2018
Figure 10.13: BD: SWOT Analysis
Figure 10.14: Boston Scientific Corporation: Product Portfolio
Figure 10.15: Boston Scientific Corporation, Overall Financials, 2016-2018
Figure 10.16: Boston Scientific Corporation, Total Sales Revenue (by Segment), 2016-2018
Figure 10.17: Boston Scientific Corporation (by Region), 2016-2018
Figure 10.18: Boston Scientific Corporation, R&D Expenditure, 2016-2018
Figure 10.19: Boston Scientific Corporation: SWOT Analysis
Figure 10.20: BTG Plc: Product Portfolio
Figure 10.21: BTG Plc, Overall Financials, 2016-2018
Figure 10.22: BTG Plc, Total Sales Revenue (by Segment), 2016-2018
Figure 10.23: BTG Plc (by Region), 2016-2018
Figure 10.24: BTG Plc, Total Sales Revenue, 2016-2018
Figure 10.25: BTG Plc: SWOT Analysis
Figure 10.26: Eckert & Ziegler BEBIG AG: Product Portfolio
Figure 10.27: Eckert & Ziegler BEBIG AG, Overall Financials, 2016-2018
Figure 10.28: Eckert & Ziegler BEBIG AG (by Region), 2016-2018
Figure 10.29: Eckert & Ziegler BEBIG AG Total Sales Revenue, 2016-2018
Figure 10.30: Eckert & Ziegler BEBIG AG: SWOT Analysis
Figure 10.31: HealthTronics, Inc.: Product Portfolio
Figure 10.32: HealthTronics, Inc.: SWOT Analysis
Figure 10.33: IceCure Medical: Product Portfolio
Figure 10.34: IceCure Medical: SWOT Analysis
Figure 10.35: Medtronic Plc: Product Portfolio
Figure 10.36: Medtronic PLC: Overall Financials, 2016-2018
Figure 10.37: Medtronic Plc, Total Sales Revenue (by Segment), 2016-2018
Figure 10.38: Medtronic Plc (by Region), 2016-2018
Figure 10.39: Medtronic PLC: R&D Expenditure
Figure 10.40: Medtronic PLC: SWOT Analysis
Figure 10.41: MedWaves, Inc.: Product Portfolio
Figure 10.42: MedWaves, Inc.: SWOT Analysis
Figure 10.43: Merit Medical Systems, Inc.: Product Portfolio
Figure 10.44: Merit Medical Systems, Inc., Overall Financials, 2016-2018
Figure 10.45: Merit Medical Systems, Inc., Total Sales Revenue (by Segment), 2016-2018
Figure 10.46: Merit Medical Systems, Inc. (by Region), 2016-2018
Figure 10.47: Merit Medical Systems, Inc., Total Sales Revenue, 2016-2018
Figure 10.48: Merit Medical Systems, Inc.: SWOT Analysis
Figure 10.49: Sanarus Technologies, Inc.: Product Portfolio
Figure 10.50: Sanarus Technologies, Inc.: SWOT Analysis
Figure 10.51: Sirtex Medical Ltd.: Product Portfolio
Figure 10.52: Sirtex Medical Ltd.: SWOT Analysis
Figure 10.53: Sonacare Medical: Product Portfolio
Figure 10.54: Sonacare Medical: SWOT Analysis
Figure 10.55: Terumo Corporation: Product Portfolio
Figure 10.56: Terumo Corporation, Overall Financials, 2015-2017
Figure 10.57: Terumo Corporation, Total Sales Revenue (by Segment), 2015-2017
Figure 10.58: Terumo Corporation, Total Sales Revenue (by Region), 2016-2018
Figure 10.59: Terumo Corporation, Total Sales Revenue, 2015-2017
Figure 10.60: Terumo Corporation: SWOT Analysis
Figure 10.61: Trod Medical: Product Portfolio
Figure 10.62: Trod Medical: SWOT Analysis
Figure 1: Global Interventional Oncology Devices Market: Market Segmentation
Figure 2: Market Statistics
Figure 3: Global Interventional Oncology Devices Market, 2018-2025
Figure 4: Market Drivers and Market Restraints
Figure 5: Financial Burden of Cancer (2015)
Figure 6: Share of Prevalence of Cancer in Global Population
Figure 7: Number of People with Cancer (by Age) in Global Population
Figure 8: Growth Share Matrix of Interventional Oncology Devices Market, by Products, 2019-2025
Figure 9: Global Interventional Oncology Devices Market, by Cancer Type, 2018 and 2025
Figure 10: Global Interventional Oncology Devices Market, by Geography, 2018 and 2025
Figure 11: Competitive Scenario
Figure 2.1: Global Interventional Oncology Devices Market: Market Segmentation
Figure 3.1: Interventional oncology devices Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.6: Assumptions and Limitations
Figure 3.7: Factors Considered for Data Prediction and Modeling
Figure 4.1: Share of Patents (by Ownership), 2015-2018
Figure 5.1: Competitive Landscape, January 2015-February 2019
Figure 5.2: Share of Key Developments and Strategies, January 2015-February 2019
Figure 5.3: Product Launches (by Company), January 2015-February 2019
Figure 5.4: Collaborations, Joint Ventures, and Partnerships Share (by Company), January 2015-February 2019
Figure 5.5: Mergers and Acquisitions Share (by Company), January 2015- February 2019
Figure 5.6: Awards and Recognition (by Company), January 2015-February 2019
Figure 5.7: Business Expansion and Others Share (by Company), January 2015- February 2019
Figure 5.8: Market Share Analysis (by Company), for Global Interventional Oncology Devices Market, 2018
Figure 6.1: Market Dynamics
Figure 6.2: Trend of Robotic Surgery, Laparoscopic Surgery and Open Surgery, as a % of Select Surgeries, 2006 to 2015, U.K.
Figure 6.3: Household Disposable Income, US$/Capita
Figure 7.1: Segmentation of Interventional Oncology Devices Market (by Cancer Type)
Figure 7.2: Global Interventional Oncology Devices Market (by Cancer type), 2018 and 2025
Figure 7.3: Global Interventional Oncology Devices Market (Liver Cancer), 2018-2025
Figure 7.4: Global Interventional Oncology Devices Market (Lung Cancer), 2018-2025
Figure 7.5: Global Interventional Oncology Devices Market (Kidney Cancer), 2018-2025
Figure 7.6: Global Interventional Oncology Devices Market (Prostate Cancer), 2018-2025
Figure 7.7: Global Interventional Oncology Devices Market (by Other Cancers), 2018-2025
Figure 8.1: Segmentation of Interventional Oncology Devices Market (by Product type)
Figure 8.2: Global Interventional Oncology Devices Market (by Product type), 2018 and 2025
Figure 8.3: Global Interventional Oncology Devices Market (Ablation Devices), 2018-2025
Figure 8.4: Ablation is mainly divided into 3 types:
Figure 8.5. : Global Interventional Oncology Devices Market (Radiofrequency ablation devices), 2018-2025
Figure 8.6: Global Interventional Oncology Devices Market (Microwave Ablation Devices), 2018-2025
Figure 8.7: Global Interventional Oncology Devices Market (by Cryoablation Ablation Devices), 2018-2025
Figure 8.8: Global Interventional Oncology Devices Market (Embolization Devices), 2018-2025
Figure 8.9: Embolization is mainly divided into three types:
Figure 8.10: Global Interventional Oncology Devices Market (Transcatheter Arterial Radioembolization Devices), 2018-2025
Figure 8.11: Global Interventional Oncology Devices Market (Transcatheter arterial chemoembolization Devices), 2018-2025
Figure 8.12: Global Interventional Oncology Devices Market (Transcatheter arterial embolization devices), 2018-2025
Figure 8.13: Global Interventional Oncology Devices Market (Supporting Devices), 2018-2025
Figure 8.14: Global Interventional Oncology Devices Market (Next Generation Devices), 2018-2025
Figure 9.1: Global Interventional Oncology Devices Market (by Region), 2018 and 2025
Figure 9.2: North America: Interventional Oncology Devices Market, 2018-2025
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America: Interventional Oncology Devices Market (by Country), 2018 and 2025
Figure 9.5: U.S.: Interventional Oncology Devices Market, 2018-2025
Figure 9.6: Canada: Interventional Oncology Devices Market, 2018-2025
Figure 9.7: Europe: Interventional Oncology Devices Market, 2018-2025
Figure 9.8: Europe: Market Dynamics
Figure 9.9: Europe: Interventional Oncology Devices Market (by Country), 2018 and 2024
Figure 9.10: Germany: Interventional Oncology Devices Market, 2018-2025
Figure 9.11: France: Interventional oncology Devices Market, 2018-2025
Figure 9.12: U.K.: Interventional Oncology Devices Market, 2018-2025
Figure 9.13: Italy: Interventional Oncology Devices Market, 2018-2025
Figure 9.14: Rest-of-Europe: Interventional Oncology Devices Market, 2018-2025
Figure 9.15: Asia-Pacific: Interventional Oncology Devices Market, 2018-2025
Figure 9.16: Asia-Pacific: Market Dynamics
Figure 9.17: Asia-Pacific: Interventional Oncology Devices Market (by Country), 2018 and 2024
Figure 9.18: China: Interventional Oncology Devices Market, 2018-2025
Figure 9.19: Japan: Interventional Oncology Devices Market, 2018-2025
Figure 9.20: India: Interventional Oncology Devices Market, 2018-2025
Figure 9.21: Australia: Interventional Oncology Devices Market, 2018-2025
Figure 9.22: Rest-of-Asia-Pacific: Interventional Oncology Devices Market, 2018-2025
Figure 9.23: Rest-of-the-World: Interventional Oncology Devices Market, 2018-2025
Figure 9.24: Latin America: Interventional Oncology Devices Market, 2018-2025
Figure 9.25: Middle East and Africa: Interventional Oncology Devices Market, 2018-2025
Figure 10.1: Number of Companies Profiled: Global Interventional Oncology Devices Market, 2018
Figure 10.2: AngioDynamics, Inc.: Product Portfolio
Figure 10.3: AngioDynamics, Inc., Overall Financials, 2016-2018
Figure 10.4: AngioDynamics Inc., Total Sales Revenue (by Segment), 2016-2018
Figure 10.5: AngioDynamics, Inc. (by Region), 2016-2018
Figure 10.6: AngioDynamics Inc., R&D Expenditure, 2016-2018
Figure 10.7: AngioDynamics, Inc.: SWOT Analysis
Figure 10.8: BD: Product Portfolio
Figure 10.9: BD, Overall Financials, 2016-2018
Figure 10.10: BD, Total Sales Revenue (by Segment), 2016-2018
Figure 10.11: BD (by Region), 2016-2018
Figure 10.12: BD, Total Sales Revenue, 2016-2018
Figure 10.13: BD: SWOT Analysis
Figure 10.14: Boston Scientific Corporation: Product Portfolio
Figure 10.15: Boston Scientific Corporation, Overall Financials, 2016-2018
Figure 10.16: Boston Scientific Corporation, Total Sales Revenue (by Segment), 2016-2018
Figure 10.17: Boston Scientific Corporation (by Region), 2016-2018
Figure 10.18: Boston Scientific Corporation, R&D Expenditure, 2016-2018
Figure 10.19: Boston Scientific Corporation: SWOT Analysis
Figure 10.20: BTG Plc: Product Portfolio
Figure 10.21: BTG Plc, Overall Financials, 2016-2018
Figure 10.22: BTG Plc, Total Sales Revenue (by Segment), 2016-2018
Figure 10.23: BTG Plc (by Region), 2016-2018
Figure 10.24: BTG Plc, Total Sales Revenue, 2016-2018
Figure 10.25: BTG Plc: SWOT Analysis
Figure 10.26: Eckert & Ziegler BEBIG AG: Product Portfolio
Figure 10.27: Eckert & Ziegler BEBIG AG, Overall Financials, 2016-2018
Figure 10.28: Eckert & Ziegler BEBIG AG (by Region), 2016-2018
Figure 10.29: Eckert & Ziegler BEBIG AG Total Sales Revenue, 2016-2018
Figure 10.30: Eckert & Ziegler BEBIG AG: SWOT Analysis
Figure 10.31: HealthTronics, Inc.: Product Portfolio
Figure 10.32: HealthTronics, Inc.: SWOT Analysis
Figure 10.33: IceCure Medical: Product Portfolio
Figure 10.34: IceCure Medical: SWOT Analysis
Figure 10.35: Medtronic Plc: Product Portfolio
Figure 10.36: Medtronic PLC: Overall Financials, 2016-2018
Figure 10.37: Medtronic Plc, Total Sales Revenue (by Segment), 2016-2018
Figure 10.38: Medtronic Plc (by Region), 2016-2018
Figure 10.39: Medtronic PLC: R&D Expenditure
Figure 10.40: Medtronic PLC: SWOT Analysis
Figure 10.41: MedWaves, Inc.: Product Portfolio
Figure 10.42: MedWaves, Inc.: SWOT Analysis
Figure 10.43: Merit Medical Systems, Inc.: Product Portfolio
Figure 10.44: Merit Medical Systems, Inc., Overall Financials, 2016-2018
Figure 10.45: Merit Medical Systems, Inc., Total Sales Revenue (by Segment), 2016-2018
Figure 10.46: Merit Medical Systems, Inc. (by Region), 2016-2018
Figure 10.47: Merit Medical Systems, Inc., Total Sales Revenue, 2016-2018
Figure 10.48: Merit Medical Systems, Inc.: SWOT Analysis
Figure 10.49: Sanarus Technologies, Inc.: Product Portfolio
Figure 10.50: Sanarus Technologies, Inc.: SWOT Analysis
Figure 10.51: Sirtex Medical Ltd.: Product Portfolio
Figure 10.52: Sirtex Medical Ltd.: SWOT Analysis
Figure 10.53: Sonacare Medical: Product Portfolio
Figure 10.54: Sonacare Medical: SWOT Analysis
Figure 10.55: Terumo Corporation: Product Portfolio
Figure 10.56: Terumo Corporation, Overall Financials, 2015-2017
Figure 10.57: Terumo Corporation, Total Sales Revenue (by Segment), 2015-2017
Figure 10.58: Terumo Corporation, Total Sales Revenue (by Region), 2016-2018
Figure 10.59: Terumo Corporation, Total Sales Revenue, 2015-2017
Figure 10.60: Terumo Corporation: SWOT Analysis
Figure 10.61: Trod Medical: Product Portfolio
Figure 10.62: Trod Medical: SWOT Analysis
